Abstract
This chapter addresses the application of ribozymes in studying an important area of cancer biology, the process of metastasis. An example is given on how ribozymes can be used to study the role in this process of one particular gene. Initially, a brief introduction to the biology of cancer metastasis is given. The procedure of selecting ribozyme target sites and constructing a ribozyme is presumed to be known by the reader. The nucleic acid sequence of the actual ribozyme is described in Subheading 2., whereas Subheading 3. focuses mainly on methods that may be original for this particular study, including assays dealing with the crucial question of whether observed phenotypic effects of introducing a ribozyme into target cells is a consequence of ribozyme activity, or merely reflects random differences in phenotypes between different cell clones. In Subheading 4. some of the difficulties and hallmarks of the above mentioned procedures are discussed, and the chapter concludes with an evaluation of the biological system used for examining putatively metastasis-associated genes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liotta, L. A and Stetler-Stevenson, W. G (1991) Tumor invasion and metastasis an imbalance of positive and negative regulation Cancer Res 51, 5054–5059.
Fodstad, Ø., and Kjønniksen, I (1994) Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis J Cell Biochem 56, 23–28
Fidler, I J. (1990) Critical factors in the biology of human cancer metastasis twenty-eighth G H A. Clowes Memorial Award lecture Cancer Res 50, 6130–6138.
MacDonald, N J and Steeg, P. S (1993) Molecular basis of tumour metastasis Cancer Surveys 16, 175–199
Liotta, L A (1992) Cancer cell invasion and metastasis. Sci Am 266, 54–59
Steeg, P. S (1991) Genetic control of the metastatic phenotype Sem Cancer Biol 2, 105–110
Steeg, P S, Bevilacqua, G, Kopper, L., Thorgeirsson, U P, Talmadge, J E, Liotta, L A., and Sobel, M. E (1988) Evidence for a novel gene associated with low tumor metastatic potential J Natl Cancer Inst 80, 200–204
de la Rosa, A., Williams, R. L, and Steeg, P S. (1995) Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions Bioessays 17, 53–62
Dong, J.-T, Lamb, P. W, Rinker-Schaeffer, C. W., Vukanovic, J, Ichikawa, T, Isaacs, J T., and Barrett, J C (1995) KAII, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2 Science 268, 884–886.
Davres, B R, Davies, M P, Gibbs, F E, Barraclough, R, and Rudland, P S (1993) Induction of the metastatic phenotype by transfection of a benign rat mammary epithehal cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1 Oncogene 8, 999–1008
Mælandsmo, G M., Hovig, E, Skrede, M, Engebraaten, O, Flørenes, V A., Myklebost, O., Grigorian, M, Lukanidin, E., Scanlon, K J, and Fodstad, Ø (1996) Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mtsl) ribozyme. Cancer Res 56, 5490–5498
Barraclough, R., Savin, J., Dube, S. K., and Rudland, P S (1987) Molecular cloning and sequence of the gene for p9Ka A cultured myoepithelial cell protein with stiong homology to S-100, a calcium-binding protein J Mol Biol 198, 13–20.
Ebralidze, A, Tulchinsky, E., Grigorian, M, Afanasyeva, A, Senin, V, Revazova, E, and Lukanidin, E (1989) Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family Genes Dev 3, 1086–1093
Kashani-Sabet, M, Funato, T, Tone, T, Jiao, L, Wang, W., Yoshida, E, Kashfinn, B. I., Shitara, T., Wu, A. M., Moreno, J. G., Traweek, S T., Ahlering, T. E, and Scanlon, K. J (1992) Reversal of the malignant phenotype by an anti-rag ribozyme Antisense Res. Dev 2, 3–15
Hilt, D. C. and Kligman, D (1991) The S-100 protein family: a biochemical and functional overview, in Novel Calcium-Binding Proteins Fundamentals of Clinical Implications (Heizmann, C. W., ed.), Springer Verlag, Berlin, pp. 65–103.
Schafer, B. W and Heizmann, C W (1996) The S 100 family of EF-hand calcium-binding proteins: functions and pathology TIBS 21, 134–140.
Fodstad, Ø, Brøgger, A., Bruland, Ø., Solheim, Ø. P, Nesland, J. M., and Pihl, A (1986) Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma Int J. Cancer 38, 33–40.
Chen, C. and Okayama, H (1987) High-efficiency transfotmation of mammalian cells by plasmid DNA. Mol Cell. Biol 7, 2745–2752
Frohman, M. A., Dush, M. K., and Martin, G. R. (1988) Rapid production of full-length cDNAs from rare transcripts. amplification using a single gene-specific oligonucleotide primer. Proc. Natl Acad. Sci. USA 85, 8998–9002.
Frohman, M. A (1993) Rapid amplification of complementary DNA ends for generanon of full-length complementary DNAs: thermal RACE Meth Enzymol 218, 340–356
Frohman, M A (1994) Cloning PCR products, in The Polymerase Chain Reaction (Mullis, K. B., Ferré, F., and Gibbs, R. A., eds.), Birkhauser, Boston, pp. 14–37.
Kjønniksen, I., Nesland, J M, Pihl, A, and Fodstad, Ø. (1990) Nude rat model for studying metastasis of human tumor cells to bone and bone marrow. J Natl. Cancer Inst. 82, 408–412
Lundeberg, J, Wahlberg, J, and Uhlen, M. (1991) Rapid calorimetric quantification of PCR-amplified DNA Biotechniques 10, 68–75.
Steinecke, P, Herget, T., and Schreier, P. H. (1992) Expression of a chimeric ribozyme gene results in endonucleolytic cleavage of target mRNA and a concomitant reduction of gene expression in vivo. EMBO J 11, 1525–1530
Scanlon, K. J., Ishida, H., and Kashani-Sabet, M (1994) Ribozyme-mediated reversal of the multidrug-resistant phenotype. Proc Natl Acad Sci USA 91, 11,123–11,127.
Saiki R. (1989) PCR Technology. Principles and Applications for DNA Amplification Stockton, New York
Hung, T., Mak, K., and Fong, K (1990) A specificity enhancer for polymerase chain reaction Nucleic Acids Res 18, 4953.
Fidler, I. J, Wilmanns, C., Staroselsky, A., Radinsky, R., Dong, Z, and Fan, D. (1994) Modulation of tumor cell response to chemotherapy by the organ environment Cancer Met Rev 13, 209–222.
Kjønniksen, I., Winderen, M., Bruland, Ø, and Fodstad, Ø (1994) Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats Cancer Res 54, 1715–1719
Rossi, J J (1994) Practical ribozymes. Making ribozymes work in cells Curr Biol. 4, 469–471.
Thompson, J. D., Macejak, D, Couture, L., and Stinchcomb, D T (1995) Ribozymes in gene therapy Nature Med 1, 277,278.
Marschall, P, Thomson, J. B, and Eckstein, F (1994) Inhibition of gene expression with ribozymes Cell Mol NeuroBiol 14, 523–538.
Sullivan, S M (1994) Development of ribozymes for gene therapy J Invest Dermatol 103, 85S–89S
Scanlon, K J, Ohta, Y, Ishida, H, Kijima, H., Ohkawa, T, Kaminski, A, Tsai, J, Horng, G., and Kashani-Sabet, M (1995) Oligonucleotide-mediated modulation of mammalian gene expression FASEB J 9, 1288–1296
Rossi, J J. (1995) Controlled, targeted, intracellular expression of ribozymes progress and problems. Trends Biotechnol 13, 301–306.
Rossi, J J (1995) Therapeutic antisense and ribozymes Br Med Bull 51, 217–225
Morgan, R A and Anderson, W F (1993) Human gene therapy Annu Rev Biochem 62, 191–217
Sullenger B A and Cech T R.(1993) Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA Science 262, 1566–1569
Terns, M P, Dahlberg, J E, and Lund, E (1993) Multiple cis-acting signals for export of pre-U1 snRNA from the nucleus Genes Dev 7, 1898–1908
Bratty, J, Chartrand, P, Ferbeyre, G, and Cedergren, R (1993) The hammerhead RNA domain, a model ribozyme Biochim Biophys Acta 1216, 345–359
Heidenreich, O, Pieken, W, and Eckstein, F (1993) Chemically modified RNA approaches and applications FASEB J 7, 90–96
Heidenreich, O, Benseler, F., Fahrenholz, A, and Eckstein, F (1994) High activity and stability of hammerhead ribozymes containing 2′-modified pyrimidme nucleosides and phosphorothioates J Biol Chem 269, 2131–2138.
Lyngstadaas, S. P., Risnes, S., Sproat, B. S, Thrane, P. S., and Prydz, H P (1995) A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo EMBO J 14, 5224–5229
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc.
About this protocol
Cite this protocol
Mælandsmo, G.M., Kjønniksen, I., Hovig, E., Scanlon, K.J., Fodstad, Ø. (1998). Ribozymes. In: Scanlon, K.J. (eds) Therapeutic Applications of Ribozymes. Methods in Molecular Medicine™, vol 11. Springer, Totowa, NJ. https://doi.org/10.1385/0-89603-477-1:241
Download citation
DOI: https://doi.org/10.1385/0-89603-477-1:241
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-477-8
Online ISBN: 978-1-59259-595-2
eBook Packages: Springer Protocols